ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Bush nominates McClellan to head CMS.

February 27, 2004

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

NCI To Offer New Grants In Preventative Oncology -Epidemiology, Biostatistics

October 26, 1979

Interview: Von Eschenbach Says His Goal Is to Speed Development of Interventions

March 29, 2002

NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation

November 13, 1992